Peer Review and the Age of Aquarius

By Sarah Greene Peer Review and the Age of Aquarius It’s time to reinvent the system that validates scientific discovery The most wonderous disruption of all: the idea that papers and data have lives beyond their original posting. This month our new column, Thought Experiment, considers whether mathematics can answer the deepest perplexities of science, such as evolution and consciousness. Here’s a corollary: Can metrics point to the great

Written bySarah Greene
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

This month our new column, Thought Experiment, considers whether mathematics can answer the deepest perplexities of science, such as evolution and consciousness. Here’s a corollary: Can metrics point to the great discoveries of science, and reward the discoverers?

Underlying this latter question is the profound truth that scientific careers are largely made or squelched by numbers that measure the import of one’s research—particularly, how often one is published in high-impact-factor (IF) journals and how often (and where) one’s papers are cited. That flaws abound in these metrics, is framed by neurobiologist Bjoern Brembs: “Without a moment’s hesitation I would fail any undergraduate who comes with a project using statistics only half as bad as the IF. But it’s good enough to determine who gets promoted and who doesn’t?”

Fortunately, scientometricians are tackling the problems. As laid out in a recent issue of Nature, alternatives to IF and the citation index ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies